FLYRCADO Drug Patent Profile
✉ Email this page to a colleague
When do Flyrcado patents expire, and what generic alternatives are available?
Flyrcado is a drug marketed by Ge Hlthcare and is included in one NDA.
The generic ingredient in FLYRCADO is flurpiridaz f-18. Additional details are available on the flurpiridaz f-18 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLYRCADO?
- What are the global sales for FLYRCADO?
- What is Average Wholesale Price for FLYRCADO?
Summary for FLYRCADO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | FLYRCADO at DailyMed |
US Patents and Regulatory Information for FLYRCADO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Hlthcare | FLYRCADO | flurpiridaz f-18 | SOLUTION;INTRAVENOUS | 215168-001 | Sep 27, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
